共 38 条
- [31] Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: amulticenter, randomized, double-blind, controlled trialJOURNAL OF HYPERTENSION, 2017, 35 (07) : 1481 - 1495Mourad, Jean-JacquesAmodeo, Celsode Champvallins, MartineBrzozowska-Villatte, RomualdaAsmar, Roland
- [32] Safety and Efficacy of a Combination of 5-Azacitidine Followed by Lenalidomide in High-Risk MDS or AML Patients with Del(5q) Cytogenetic Abnormalities - Results of the "AZALE" TrialBLOOD, 2011, 118 (21) : 1623 - 1623Platzbecker, UweGanster, ChristinaNeesen, JuergenKuendgen, AndreaGoetze, KatharinaBug, GesineShirneshan, KatayoonBraulke, FriederikeRoellig, ChristophNaumann, RalphBuessemaker, EckhardGiagounidis, AristotelesHofmann, Wolf-KarstenGerming, UlrichHaase, DetlefEhninger, Gerhard
- [33] Comparative Efficacy and Safety Profile of Amlodipine 5 mg/Losartan 50 mg Fixed-Dose Combination and Amlodipine 10 mg Monotherapy in Hypertensive Patients Who Respond Poorly to Amlodipine 5 mg Monotherapy: An 8-Week, Multicenter, Randomized, Double-Blind Phase III Noninferiority StudyCLINICAL THERAPEUTICS, 2011, 33 (12) : 1953 - 1963Kang, Seok-MinYoun, Jong-ChanChae, Shung ChullPark, Chang GyuYang, Joo YoungKim, Moo HyunHong, Taek JongKim, Cheol HoKim, Jae JoongShin, Dong GuJung, Jin WonYoon, Jung HanPark, Si HoonKwon, JunCho, Seung Yun
- [34] The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extensionHypertension Research, 2017, 40 : 51 - 60Jitsuo HigakiIssei KomuroKosuke ShikiHiroyuki UgaiAtsushi TaniguchiHiroshi IkedaDaisuke KurokiSeiichiro NishimuraToshio Ogihara
- [35] The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extensionHYPERTENSION RESEARCH, 2017, 40 (01) : 51 - 60Higaki, JitsuoKomuro, IsseiShiki, KosukeUgai, HiroyukiTaniguchi, AtsushiIkeda, HiroshiKuroki, DaisukeNishimura, SeiichiroOgihara, Toshio
- [36] Comparative Efficacy and Safety Profile of Amlodipine 5 mg/Losartan 50 mg Fixed-Dose Combination and Amlodipine 10 mg Monotherapy in Hypertensive Patients Who Respond Poorly to Amlodipine 5 mg Monotherapy: An 8-Week, Multicenter, Randomized, Double-Blind Phase III Noninferiority Study (vol 33, pg 1953, 2011)CLINICAL THERAPEUTICS, 2012, 34 (08) : 1844 - 1844Kang, S. M.
- [37] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)ENDOCRINOLOGY AND METABOLISM, 2024, 39 (05) : 722 - 731Kim, Nam HoonLee, JuneyoungChon, SukYu, Jae MyungJeong, In-KyungLim, SooKim, Won JunSong, KeehoCho, Ho ChanYu, Hea MinKim, Kyoung-AhKim, Sang SooLee, Soon HeeKim, Chong HwaKwak, Soo HeonLee, Yong-hoChung, Choon HeeLee, SihoonJin, Heung YongLee, Jae HyukKoh, GwanpyoKim, Sang-YongKim, JaetaekLee, Ju HeeKim, Tae NyunJeon, Hyun JeongLee, Ji HyunJeon, Jae-HanYoo, Hye JinKim, Hee KyungPark, Hyeong-KyuNam-Goong, Il SeongHong, SeongbinAhn, Chul WooYu, Ji HeePark, Jong HeonPark, Keun-GyuPark, Chan HoJoung, Kyong HyeRyu, Ohk-HyunPark, Keun YongHong, Eun-GyoungCha, Bong-SooWon, Kyu ChangChung, Yoon-SokKim, Sin Gon
- [38] Efficacy and safety of Huashi Baidu granule plus Nirmatrelvir-Ritonavir combination therapy in patients with high-risk factors infected with Omicron (B.1.1.529): A multi-arm single-center, open-label, randomized controlled trialPHYTOMEDICINE, 2023, 120Yu, ZhuoZheng, YanxiChen, BowuLv, JiaZhu, XiaojunShang, BinyiXv, YupingTao, RuYang, YanbingCong, JunLi, DanWu, HuanQv, WenchaoZhang, XiyiXv, ChengbinFeng, HaiYuan, WeianGao, Yueqiu